Continuing GLP-1/GIP agonist therapy prior to elective upper endoscopy increases the risk for residual gastric volume, but clear liquids the day before could mitigate the risk.

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate ...

New DLBCL trials test bispecifics with chemo, BTK add-ons, and MRD-guided preemptive allo CAR-T to cut relapse risk. The treatment landscape for newly diagnosed diffuse large B-cell lymphoma is on the ...

Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial In this global phase III ...

Want to learn more about the cutting-edge science of metabolic psychiatry? This webinar will explore metabolic therapies for ...

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.

In a study published in NEJM Catalyst, Mayo Clinic researchers demonstrate that chemotherapy can be safely delivered in ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...